Cancer BiologybioRxiv
Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer
S. Borgoni, E. Sofyali, M. Soleimani Dodaran…·S. Wiemann
This study identifies ATF3 as a novel mediator of endocrine resistance in breast cancer through time-resolved profiling and validates its role in key signaling pathways and clinical relevance.